Emeraid

NEWS

Press Release — 2024.12.03

Back to News

Emeraid, a University of Tokyo Healthcare AI-DX Venture, Starts Collaboration Project with Integrity Healthcare

2024.12.03Press Release
Emeraid, a University of Tokyo Healthcare AI-DX Venture, Starts Collaboration Project with Integrity Healthcare

Emeraid, Inc., a University of Tokyo startup challenging the optimization and sustainability of the medical and healthcare industry through AI-DX using cutting-edge technologies including AI, and Integrity Healthcare, Inc. have announced the start of a collaborative project in the pharmaceutical industry.

For partnership inquiries or joint research discussions, please feel free to contact us.

About Integrity Healthcare, Inc.

A medical tech company that aims to create the future of medicine through the fusion of people and technology. By combining cutting-edge ICT technology with medical know-how, they develop YaDoc — a disease management system that contributes to improving the quality of care by deepening two-way communication between doctors and patients, YaDoc Quick — an online medical consultation system, and Smart One Health — a PHR management system.

  • -Company: Integrity Healthcare, Inc.
  • -Founded: October 2009
  • -Representatives: Chairman Shinsuke Muto, President Ai Sonoda
  • -Business: Provision of disease management systems and online medical consultation systems utilizing technology
  • -Location: YAMATO B.L.D, 1-27-5 Nihonbashi Kakigaracho, Chuo-ku, Tokyo

About Emeraid, Inc.

Emeraid is a University of Tokyo venture company that upholds the philosophy of "A society where everyone can face 'living' head-on," aiming to optimize and sustain healthcare — the very infrastructure of life — through AI-DX. Leveraging domain knowledge and problem understanding specialized in the healthcare industry, combined with cutting-edge technology centered on AI, Emeraid creates future-oriented solutions for the complex challenges faced by medical institutions and companies.

Built on its proprietary Healthcare AI Platform "SUI" — a technology foundation developed through in-house R&D and medical research — the company provides a Solutions Business offering end-to-end support spanning AI, software, and hardware, from issue analysis to system development and operational improvement, as well as Medical Data Analytics grounded in bioinformatics and chemoinformatics for clinical research and trials.

  • -Company: Emeraid, Inc.
  • -Founded: February 2024
  • -Representative: CEO Rikuto Shima
  • -Location: Sobunkan Bldg. 3F, 6-25-14 Hongo, Bunkyo-ku, Tokyo